《大行》高盛首予寧德時代(03750.HK)目標價343元 評級「買入」
高盛重申對寧德時代A股(300750.SZ)的「買入」評級及323元人民幣目標價,並首予寧德時代H股(03750.HK)目標價343元,評級「買入」。
該行料公司2024至2030年每股盈利年均複合增長率達25%,受強勁銷量增長、產品組合改善及單位盈利擴張推動,且按一年預測市盈率估值較南韓LG能源方案及國軒高科(002074.SZ)有顯著折讓,認為寧德時代A股及港股估值均吸引。
該行料寧德時代綜合單位毛利將由今年的每千瓦時152元人民幣升至2030年的每千瓦時169元人民幣。公司料在未來五年保持全球約四成市佔,奠基於中國本土市場的供應整合及在歐洲與其他地區的強勁地位,有效抵銷美國市場逆風。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.